Micropharma (intellectual property assets)

Business Data, Corporate Office and Headquarter Address

About

Micropharma (intellectual property assets) is Buildings and Property in Canada that focus on reuteri NCIMB business. They cover business area such as portfolio, intellectual property asset, development, Lactobacillus reuteri NCIMB, LRC, probiotic, two family, register patent.

Business Type

Buildings and Property

Country

Canada

Founded

-

Company Focus

Reuteri NCIMB

Website

-

Corporate Office and Headquarter Office address:

Montreal
Canada

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

portfoliointellectual property assetdevelopmentLactobacillus reuteri NCIMBLRCprobiotictwo familyregister patent

* We use standard office opening hours in near Micropharma (intellectual property assets)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Micropharma (intellectual property assets) Frequently Asked Questions

What or who is Micropharma (intellectual property assets)?

Micropharma (intellectual Property Assets) is Buildings and Property business from Canada that founded in - ( years old in ), Micropharma (intellectual property assets) business is focusing on Reuteri NCIMB.

Where is Micropharma (intellectual property assets) headquarter and corporate office address?

Micropharma (intellectual property assets) headquarter office and corporate office address is located in Montreal Canada.

Where is Micropharma (intellectual property assets) country origins?

Micropharma (intellectual property assets) was founded in Canada.

What is Reuteri NCIMB business focus on?

In , Micropharma (intellectual property assets) is currently focus on reuteri NCIMB sector.

Reuteri NCIMB Business Interest from Google Trend

Above is snippet of Google Trends for "reuteri NCIMB" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Micropharma (intellectual property assets), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.